Oracle Launches the $20 Billion Raise It Capped Itself At Five Days Ago

Oracle launched a $10 billion stock sale and a $10 billion bond sale on Monday, using the full $20 billion it allowed itself through fiscal 2030.

Shares fell 4% in premarket trading on Monday. That reading is a premarket snapshot reported at 9:03 a.m. ET. The stock had already fallen 61% from its peak close in September 2025.

Two sales, and neither waits for the other

Oracle is offering $10 billion of common stock. A separate filing offers $10 billion of senior notes, which are bonds the company must repay. Neither sale depends on the other closing.

Both filings are preliminary prospectus supplements, the documents that launch a sale before final terms are set. Both were filed on Monday under a new shelf registration. A shelf registration lets a company sell securities in pieces over time.

The stock filing gives a reference price, not a sale price. The last reported sale price was $130.67 a share on October 30. The actual offering price will be set when the sale prices.

The notes run from 2029 to 2046

The bond sale has six parts. One part pays a floating rate, meaning its interest resets with a benchmark, and matures in 2029. Five fixed-rate parts mature in 2029, 2031, 2033, 2037 and 2046.

The size of each part is still blank in the filing. So are the interest rates on the fixed-rate notes. The floating-rate part will pay compounded SOFR, a benchmark rate, plus a spread that is not yet set.

The cap was set five days ago

At its Investor Day on October 28, Oracle committed to a limit. It said additional capital-market fundraising through fiscal 2030 would stay at $20 billion. The expected split was $10 billion in stock and $10 billion in gross debt.

The cap excludes refinancing of existing debt. Monday's two sales match the cap's amount and its split exactly. Oracle also said the cap comes on top of a separate sale already finished.

That finished sale was a $20 billion at-the-market program, completed in the first quarter of fiscal 2027. An at-the-market program sells shares gradually into the market at current prices. It is separate from the new $20 billion.

What the money is for

Both filings use the same broad language. Proceeds go to general corporate purposes. The filings list capital expenditures, debt repayment, future investments or acquisitions, and dividends or share buybacks.

Capital expenditures here mean the data centers and equipment behind Oracle's cloud buildout. The filings do not assign a dollar amount to any single use. How much, if any, refinances existing debt is not stated.

The dilution math, labeled as a calculation

Oracle had about three billion twenty-four million shares outstanding on August 31. At the $130.67 reference price, $10 billion would require roughly seventy-six and a half million new shares. That is a calculation from the filing's figures, not an amount raised.

On those same figures, the new shares would add about 2.5% to the share count. The final count depends on the actual offering price. A lower price means more shares for the same $10 billion.

The October 28 outlook frames why Oracle wants the money now. It targets revenue of $225 billion or more in fiscal 2030. It expects capital spending to peak in fiscal 2027 and 2028, then step down.

What remains unknown

What remains unknown starts with pricing. The stock sale's price and share count are not set. The notes' tranche sizes, rates and spreads are also not set, and final pricing had not landed when this article was written.

Also unknown is the split of the proceeds. The filings do not say how much goes to capital spending versus debt repayment. Whether any of the notes count as refinancing, which the cap excludes, is not stated either.

What to watch next

What to watch begins with the pricing statements for both sales. Final terms will show the true cost of the debt and the true dilution from the stock. Watch also whether Oracle treats this raise as completing its fundraising through fiscal 2030, as the cap implies.